CEP43 and myeloproliferative disorder: Other notable fusions, such as BCR-FGFR1, FGFR1OP-RET, and FGFR1OP-FGFR1, are associated with myeloproliferative disorders, contributing to disease onset and progression by promoting cell cycle progression and suppressing apoptosis.